参考文献/References:
[1] Turki-Judeh W,Courey AJ.Groucho:A corepressor with instructive roles in development[J].Curr Top Dev Biol,2012,98:65-96.
[2] Buscarlet M,Stifani S.The Marx of groucho on development and disease[J].Trends Cell Biol,2007,17(7):353-361.
[3] Chodaparambil JV,Pate KT,Hepler MR,et al.Molecular functions of the TLE tetramerization domain in Wnt target gene repression[J].EMBO J,2014,33(7):719-731.
[4] Ali SA,Zaidi SK,Dobson JR,et al.Transcriptional corepressor TLE1 functions with Runx2 in epigenetic repression of ribosomal RNA genes[J].Proc Natl Acad Sci USA,2010,107(9):4165-4169.
[5] Xu JH,Chen GC,Huang CZ,et al.Epigenetic modification of TLE1 induce abnormal differentiation in diabetic mice intestinal epithelium[J].Mol Cell Biochem,2018,438(1-2):85-96.
[6] Ramasamy S,Saez B,Mukhopadhyay S,et al.TLE1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-kappaB inflammatory pathway[J].Proc Natl Acad Sci USA,2016,113(7):1871-1876.
[7] Yao X,Ireland SK,Pham T,et al.TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin[J].Biochem Biophys Res Commun,2014,455(3-4):277-284.
[8] Allen T,van Tuyl M,Iyengar P,et al.Grg1 acts as a lung-specific oncogene in a transgenic mouse model[J].Cancer Res,2006,66(3):1294-1301.
[9] Yao X,Pham T,Temple B,et al.TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression[J].Oncotarget,2017,8(42):72235-72249.
[10] Lee JH,Bae SB,Oh MH,et al.Clinicopathologic and prognostic significance of transducin-like enhancer of split 1 protein expression in invasive breast cancer[J].J Breast Cancer,2017,20(1):45-53.
[11] Brunquell C,Biliran H,Jennings S,et al.TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells[J].Mol Cancer Res,2012,10(11):1482-1495.
[12] Zahavi T,Maimon A,Kushnir T,et al.Ras-Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor function[J].Oncogene,2017,36(26):3729-3739.
[13] Holmes KA,Hurtado A,Brown GD,et al.Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells[J].Proc Natl Acad Sci USA,2012,109(8):2748-2753.
[14] Lee JH,Son MW,Kim KJ,et al.Prognostic and clinicopathological significance of transducer-like enhancer of split 1 expression in gastric cancer[J].J Gastric Cancer,2016,16(1):21-27.
[15] Liu G,Jiang Z,Qiao M,et al.Lnc-GIHCG promotes cell proliferation and migration in gastric cancer through miR-1281 adsorption[J].Mol Genet Genomic Med,2019,7(6):e711.
[16] Fraga MF,Berdasco M,Ballestar E,et al.Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies[J].Cancer Res,2008,68(11):4116-4122.
[17] Jagdis A,Rubin BP,Tubbs RR,et al.Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma[J].Am J Surg Pathol,2009,33(12):1743-1751.
[18] 吕京澴,王 璇,王小桐,等.TLE1在单相梭形细胞型及低分化型滑膜肉瘤中的诊断价值[J].诊断病理学杂志,2017,24(3):215-219.
[19] Valente AL,Tull J,Zhang S.Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma[J].Appl Immunohistochem Mol Morphol,2013,21(5):408-413.
[20] Kosemehmetoglu K,Vrana JA,Folpe AL.TLE1 expression is not specific for synovial sarcoma:A whole section study of 163 soft tissue and bone neoplasms[J].Mod Pathol,2009,22(7):872-878.
[21] Rekhi B,Basak R,Desai SB,et al.Immunohistochemical validation of TLE1,a novel marker,for synovial sarcomas[J].Indian J Med Res,2012,136(5):766-775.
[22] Alegria-Landa V,Najera L,Massa DS,et al.Primary subcutaneous synovial sarcoma:First reported subcutaneous case showing TLE1 immunoreactivity[J].Am J Dermatopathol,2018,40(10):772-777.
[23] Morrell TJ,Xiong Y,Deng A,et al.Expression of TLE1 in malignant melanoma with spindle cell morphology:A potential diagnostic pitfall[J].Int J Surg Pathol,2019,27(3):259-262.
[24] Bozdogan N,Dilek GB,Benzer E,et al.Transducing-like enhancer of split 1:A potential immunohistochemical marker for glomus tumor[J].Am J Dermatopathol,2017,39(7):524-527.
[25] Zaccarini DJ,Deng X,Tull J,et al.Expression of TLE-1 and CD99 in carcinoma:Pitfalls in diagnosis of synovial sarcoma[J].Appl Immunohistochem Mol Morphol,2018,26(6):368-373.